Opportunistic viral infections can cause serious morbidity and mortality in immunocompromised patients after allogeneic stem cell transplantation. Clinical studies have shown that adoptive transfer of donor-derived T cells specific for cytomegalovirus (CMV), Epstein-Barr virus (EBV), or human adenovirus (HAdV) can be a safe and effective treatment of infections with these major viral pathogens. The aim of this study was to develop a method for the simultaneous isolation of coordinated CD8(+) and CD4(+) memory T-cell responses against a broad repertoire of viral epitopes. To ensure that the method was applicable to a wide variety of virus-specific T cells that may differ in phenotypic and functional properties, we focused on T cells specific...
We studied the recovery of CMV-specific CD4(+) and CD8(+) T-cell immunity in 52 recipients of alloge...
We studied the recovery of CMV-specific CD4(+) and CD8(+) T-cell immunity in 52 recipients of alloge...
We studied the recovery of CMV-specific CD4(+) and CD8(+) T-cell immunity in 52 recipients of alloge...
Background aims. Adoptive transfer of cytomegalovirus (CMV)-specific memory T cells can be used for ...
Background aims. Adoptive transfer of cytomegalovirus (CMV)-specific memory T cells can be used for ...
Background: Adoptive transfer of virus-specific T cells may accelerate reconstitution of antigen-spe...
Background: Adoptive transfer of virus-specific T cells may accelerate reconstitution of antigen-spe...
Background: Adoptive transfer of virus-specific T cells may accelerate reconstitution of antigen-spe...
Background Virus-specific CD4 and CD8 T lymphocytes from HLA-matched donors are effective for treatm...
Background Human adenovirus can cause morbidity and mortality in immunocompromised patients after al...
Prophylactic infusion of selected donor T cells can be an effective method to restore specific immun...
Abstract Background Allogeneic hematopoietic stem cell transplantation (HSCT) can expose patients to...
AbstractAdoptive immunotherapy with virus-specific T lymphocytes can efficiently reconstitute antivi...
AbstractNonselective T-cell depletion reduces the incidence of severe graft-versus-host disease afte...
Reactivation of human cytomegalovirus (CMV) is hazardous to patients undergoing allogeneic cord bloo...
We studied the recovery of CMV-specific CD4(+) and CD8(+) T-cell immunity in 52 recipients of alloge...
We studied the recovery of CMV-specific CD4(+) and CD8(+) T-cell immunity in 52 recipients of alloge...
We studied the recovery of CMV-specific CD4(+) and CD8(+) T-cell immunity in 52 recipients of alloge...
Background aims. Adoptive transfer of cytomegalovirus (CMV)-specific memory T cells can be used for ...
Background aims. Adoptive transfer of cytomegalovirus (CMV)-specific memory T cells can be used for ...
Background: Adoptive transfer of virus-specific T cells may accelerate reconstitution of antigen-spe...
Background: Adoptive transfer of virus-specific T cells may accelerate reconstitution of antigen-spe...
Background: Adoptive transfer of virus-specific T cells may accelerate reconstitution of antigen-spe...
Background Virus-specific CD4 and CD8 T lymphocytes from HLA-matched donors are effective for treatm...
Background Human adenovirus can cause morbidity and mortality in immunocompromised patients after al...
Prophylactic infusion of selected donor T cells can be an effective method to restore specific immun...
Abstract Background Allogeneic hematopoietic stem cell transplantation (HSCT) can expose patients to...
AbstractAdoptive immunotherapy with virus-specific T lymphocytes can efficiently reconstitute antivi...
AbstractNonselective T-cell depletion reduces the incidence of severe graft-versus-host disease afte...
Reactivation of human cytomegalovirus (CMV) is hazardous to patients undergoing allogeneic cord bloo...
We studied the recovery of CMV-specific CD4(+) and CD8(+) T-cell immunity in 52 recipients of alloge...
We studied the recovery of CMV-specific CD4(+) and CD8(+) T-cell immunity in 52 recipients of alloge...
We studied the recovery of CMV-specific CD4(+) and CD8(+) T-cell immunity in 52 recipients of alloge...